General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen, Astra Zeneca, Bayer, BMS, Boehringer Ingelheim, Eli Lilly, Esperion, Janssen, Merck, New Amsterdam, Novo Nordisk, Novartis, Silence Therapeutics, and Pfizer(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Esperion, Amgen(SIGNIFICANT)

View Full Disclosure